Getinge enters transplant market, buying organ transport specialist Paragonix for $477M

Fierce Biotech August 26, 2024
Conor Hale

Organ preservation and transport company Paragonix Technologies has agreed to be acquired through a $477 million deal offered by Getinge—which expects the international transplant market to continue growing by double digits and top $10 billion by 2033.

Since its founding in 2010, Paragonix has worked to reshape how clinicians shepherd donor organs to the patients that need them by offering a major upgrade over the traditional methods of relying on simple, consumer-grade coolers and ice.

The company’s GPS-tracked systems employ temperature- and pressure-controlled containers that transport heart and lung tissue without causing excess cellular damage—as a result, the safeguarded organs have demonstrated fewer severe complications among patients after implantation.

More recently, Paragonix began rolling out the first FDA-approved hardware for...

Today's Sponsors

Today's Sponsor